Clinical Trial Update: Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced ATG plus mini post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in haploidentical stem cell transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)
• post-transplant cyclophosphamide (cyclophosphamide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Myelodysplastic Syndrome, Acute Leukemia | Phase 2 | Status: RECRUITING